Ascentawits Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A1
  • Latest Deal Amount
  • $14.3M
Latest Deal Amount
  • Investors
  • 5

Ascentawits General Information

Description

Developer of anti-tumor drugs. The company utilizes specific tumor micro-environments to carry out independent innovative drug designs and screening for the development of new anti-tumor drugs, providing effective drugs for cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Room 1003, 10th Floor, Building 10, Biomedical Innovation Industrial Park
  • No. 14 Jinhui Road, Pingshan District
  • Shenzhen, Guangdong
  • China
+86 0755 0000 0000

Ascentawits Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascentawits Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A1) 31-Dec-2019 $14.3M 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC 27-Mar-2017 Completed Clinical Trials - Phase 1
To view Ascentawits’s complete valuation and funding history, request access »

Ascentawits Executive Team (1)

Name Title Board Seat Contact Info
Jianxin Duan Chief Executive Officer, Founder, General Manager & Chairman
To view Ascentawits’s complete executive team members history, request access »

Ascentawits Board Members (1)

Name Representing Role Since
Jianxin Duan Ascentawits Chief Executive Officer, Founder, General Manager & Chairman 000 0000
To view Ascentawits’s complete board members history, request access »

Ascentawits Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cowin Capital Venture Capital Minority 000 0000 000000 0
Shenzhen Guozhong Venture Capital Management Venture Capital Minority 000 0000 000000 0
Sangel Capital Venture Capital Minority 000 0000 000000 0
Zhuzhou CRRC Times Corporation Minority 000 0000 000000 0
BGI Co-Win Corporate Venture Capital 000 0000 000000 0
To view Ascentawits’s complete investors history, request access »